ZNF836
gene geneOn this page
Also known as FLJ16287
Summary
ZNF836 (zinc finger protein 836, HGNC:34333) is a protein-coding gene on chromosome 19q13.33, encoding Zinc finger protein 836 (Q6ZNA1). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 162962 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 131 total
- MANE Select transcript:
NM_001102657
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34333 |
| Approved symbol | ZNF836 |
| Name | zinc finger protein 836 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ16287 |
| Ensembl gene | ENSG00000196267 |
| Ensembl biotype | protein_coding |
| Entrez | 162962 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000596428, ENST00000597065, ENST00000597252, ENST00000599618, ENST00000602187, ENST00000682614, ENST00000884043, ENST00000938682
RefSeq mRNA: 1 — MANE Select: NM_001102657
NM_001102657
CCDS: CCDS46162
Canonical transcript exons
ENST00000682614 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003103547 | 52171336 | 52171621 |
| ENSE00003491791 | 52168058 | 52168152 |
| ENSE00003518295 | 52160465 | 52160591 |
| ENSE00003531094 | 52169648 | 52169781 |
| ENSE00003920872 | 52154107 | 52157540 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 95.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.6511 / max 100.4753, expressed in 1669 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182518 | 3.3133 | 1174 |
| 182519 | 2.0433 | 1165 |
| 182520 | 1.2944 | 867 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 95.84 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.15 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.73 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 88.37 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.36 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 87.31 | gold quality |
| adrenal gland | UBERON:0002369 | 87.23 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.91 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.53 | gold quality |
| adrenal cortex | UBERON:0001235 | 86.28 | gold quality |
| tendon | UBERON:0000043 | 85.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.42 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 84.99 | gold quality |
| cortical plate | UBERON:0005343 | 84.86 | gold quality |
| left ovary | UBERON:0002119 | 84.69 | gold quality |
| sperm | CL:0000019 | 83.86 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.94 | gold quality |
| right ovary | UBERON:0002118 | 82.59 | gold quality |
| right lung | UBERON:0002167 | 81.95 | gold quality |
| adenohypophysis | UBERON:0002196 | 81.79 | gold quality |
| ovary | UBERON:0000992 | 81.23 | gold quality |
| popliteal artery | UBERON:0002250 | 80.93 | gold quality |
| tibial artery | UBERON:0007610 | 80.92 | gold quality |
| granulocyte | CL:0000094 | 80.81 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 80.78 | gold quality |
| body of uterus | UBERON:0009853 | 80.42 | gold quality |
| aorta | UBERON:0000947 | 80.33 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 80.31 | gold quality |
| ectocervix | UBERON:0012249 | 80.23 | gold quality |
| sural nerve | UBERON:0015488 | 80.23 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.17 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2573.1 | ZNF836 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 836 — Q6ZNA1 (reviewed: Q6ZNA1)
All UniProt accessions (4): M0QYS4, M0QZ88, M0R1N4, Q6ZNA1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001096127* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (33 total): zinc finger region 25, sequence conflict 4, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZNA1-F1 | 70.23 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOCC_NUCLEOLUS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ID1_TARGET_GENES, SKIL_TARGET_GENES, TFEB_TARGET_GENES, ZNF274_TARGET_GENES, ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN, GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS, GSE2706_R848_VS_LPS_2H_STIM_DC_UP, GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS, chr19q13
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleolus (GO:0005730), microtubule cytoskeleton (GO:0015630)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| cytoskeleton | 1 |
Protein interactions and networks
STRING
254 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF836 | IPP | Q9Y573 | 524 |
| ZNF836 | ZNG1F | Q4V339 | 430 |
| ZNF836 | DTWD1 | Q8N5C7 | 378 |
| ZNF836 | TMEM240 | Q5SV17 | 373 |
| ZNF836 | ZMAT1 | Q5H9K5 | 367 |
| ZNF836 | SLC25A30 | Q5SVS4 | 367 |
| ZNF836 | SERPINB12 | Q96P63 | 360 |
| ZNF836 | KCTD17 | Q8N5Z5 | 322 |
| ZNF836 | ABRA | Q8N0Z2 | 302 |
| ZNF836 | RABGAP1 | Q9Y3P9 | 294 |
| ZNF836 | SDK2 | Q58EX2 | 290 |
| ZNF836 | STXBP4 | Q6ZWJ1 | 289 |
| ZNF836 | MYRFL | Q96LU7 | 289 |
| ZNF836 | LCMT1 | Q9UIC8 | 288 |
| ZNF836 | KCNG4 | Q8TDN1 | 287 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF562 | MDM2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF836 | TBCD | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF836 | TCP11L1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| APP | ZNF836 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): TBCD (Affinity Capture-MS), TCP11L1 (Affinity Capture-MS), ZNF836 (Affinity Capture-MS), ZNF836 (Affinity Capture-MS), ZNF836 (Two-hybrid), ZNF836 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDP4, A6NHJ4, O94892, P0CJ79, P17014, P17021, P17025, P17032, P17035, P18733, P51508, P51814, Q06730, Q06732, Q09FC8, Q0VGE8, Q14586, Q32M78, Q3MIS6, Q5JVG2, Q5R4K8, Q5R9S5, Q5RBQ3, Q5RCJ2, Q5RER9, Q5TYW1, Q5VIY5, Q6P560, Q6PDB4, Q6ZMW2, Q6ZN06, Q6ZNA1, Q76KX8, Q7L2R6, Q86Y25, Q8N184, Q8N823, Q8N883, Q8N8J6, Q8NEP9
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
131 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 119 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
716 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52160460:CTTA:C | donor_loss | 1.0000 |
| 19:52160462:TACCC:T | donor_loss | 1.0000 |
| 19:52160463:A:AC | donor_gain | 1.0000 |
| 19:52160463:AC:A | donor_gain | 1.0000 |
| 19:52160463:ACCCA:A | donor_loss | 1.0000 |
| 19:52160464:C:CC | donor_gain | 1.0000 |
| 19:52160464:CC:C | donor_gain | 1.0000 |
| 19:52160587:GGTCC:G | acceptor_gain | 1.0000 |
| 19:52160588:GTCC:G | acceptor_gain | 1.0000 |
| 19:52160589:TCC:T | acceptor_gain | 1.0000 |
| 19:52160590:CC:C | acceptor_gain | 1.0000 |
| 19:52160590:CCC:C | acceptor_gain | 1.0000 |
| 19:52160591:CC:C | acceptor_gain | 1.0000 |
| 19:52160592:C:A | acceptor_loss | 1.0000 |
| 19:52160592:C:CC | acceptor_gain | 1.0000 |
| 19:52160593:T:C | acceptor_loss | 1.0000 |
| 19:52168152:TCTG:T | acceptor_loss | 1.0000 |
| 19:52168153:C:CA | acceptor_loss | 1.0000 |
| 19:52171332:TTA:T | donor_loss | 1.0000 |
| 19:52171333:TA:T | donor_loss | 1.0000 |
| 19:52171334:A:AC | donor_gain | 1.0000 |
| 19:52171335:C:CT | donor_gain | 1.0000 |
| 19:52171335:CTTG:C | donor_gain | 1.0000 |
| 19:52160463:ACC:A | donor_gain | 0.9900 |
| 19:52160464:CCC:C | donor_gain | 0.9900 |
| 19:52160589:TCCC:T | acceptor_gain | 0.9900 |
| 19:52160592:C:T | acceptor_gain | 0.9900 |
| 19:52160597:A:AC | acceptor_gain | 0.9900 |
| 19:52168052:TTTTA:T | donor_loss | 0.9900 |
| 19:52168053:TTTA:T | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000094793 (19:52168660 C>G,T), RS1000143487 (19:52163497 G>A,C), RS1000381772 (19:52157908 T>C), RS1000441395 (19:52169607 CA>C,CAA,CAAA), RS1000494228 (19:52163595 A>C), RS1000830694 (19:52159731 T>C), RS1000871211 (19:52168776 G>A), RS1001179777 (19:52160040 G>A), RS1001454600 (19:52165760 C>A,G,T), RS1001717412 (19:52170764 T>C), RS1002025081 (19:52172641 A>G), RS1002106118 (19:52171014 A>G), RS1002211638 (19:52164152 G>A), RS1002363407 (19:52169473 T>C,G), RS1002422457 (19:52169199 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Particulate Matter | increases expression | 2 |
| urushiol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| pentabromodiphenyl ether | increases expression | 1 |
| torcetrapib | increases expression | 1 |
| abrine | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Succimer | affects cotreatment, decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Fluorescein-5-isothiocyanate | affects binding | 1 |
| Lactic Acid | decreases expression | 1 |
| Magnetite Nanoparticles | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.